within Pharmacolibrary.Drugs.ATC.C;

model C01CX08
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.05,
    adminDuration  = 600,
    adminMass      = 0.012,
    adminCount     = 1,
    Vd             = 0.0002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Levosimendan is a calcium sensitizer and potassium channel opener used for short-term treatment of acute decompensated severe chronic heart failure in adults. It enhances myocardial contractility without increasing myocardial oxygen demand. It is approved in various countries but not in the United States.</p><h4>Pharmacokinetics</h4><p>Population pharmacokinetics in adult patients with severe heart failure following intravenous administration.</p><h4>References</h4><ol><li><p>Puttonen, J, et al., &amp; Pentikäinen, PJ (2008). Pharmacokinetics of intravenous levosimendan and its metabolites in subjects with hepatic impairment. <i>Journal of clinical pharmacology</i> 48(4) 445–454. DOI:<a href=&quot;https://doi.org/10.1177/0091270007313390&quot;>10.1177/0091270007313390</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18303124/&quot;>https://pubmed.ncbi.nlm.nih.gov/18303124</a></p></li><li><p>Grześk, G, et al., &amp; Dobosiewicz, M (2022). The importance of pharmacokinetics, pharmacodynamic and repetitive use of levosimendan. <i>Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie</i> 153 113391–None. DOI:<a href=&quot;https://doi.org/10.1016/j.biopha.2022.113391&quot;>10.1016/j.biopha.2022.113391</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36076524/&quot;>https://pubmed.ncbi.nlm.nih.gov/36076524</a></p></li><li><p>Figgitt, DP, et al., &amp; Goa, KL (2001). Levosimendan. <i>Drugs</i> 61(5) 613–629. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200161050-00006&quot;>10.2165/00003495-200161050-00006</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11368286/&quot;>https://pubmed.ncbi.nlm.nih.gov/11368286</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C01CX08;
